The global pharmaceutical industry relies heavily on water for manufacturing the majority of drug products. Water is used at various stages of pharmaceutical manufacturing right from active ingredient synthesis, tablet production to cleaning and sterilization of equipment. Pharmaceutical grade water plays a vital role in maintaining product quality and safety during the manufacturing process. It acts as a solvent, reactant or processing aid and helps deliver accurate drug dosage forms. Any impurities present in water can potentially contaminate drug substances and formulations, posing serious health risks. Hence, highly purified water meeting strict quality standards set by regulatory bodies like USP and EP is essential. With growing healthcare needs worldwide and tightening regulations, production of sterile and non-sterile drugs is witnessing considerable expansion. This is driving the demand for pharmaceutical water treatment systems across manufacturing facilities.
The global Pharmaceutical Water Market is estimated to be valued at 6.26 billion in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends witnessed in the global pharmaceutical water market is the rising adoption of ultrafiltration technology. Ultrafiltration is gaining popularity for the production of high-purity water used in critical applications such as sterile manufacturing. It effectively removes suspended particulate matter, colloids, proteins, bacteria, endotoxins and pyrogens. Major market players are focusing on launching advanced ultrafiltration systems equipped with features like automated cleaning-in-place (CIP) cycles and built-in membrane integrity testing port to streamline pharmaceutical water production. Another trend is the increasing preference for ion exchange resins over traditional deionization techniques. Ion exchange resins offer advantages like compact design, continuous operation and on-site regeneration, reducing wastewater generation and operational costs compared to deionization systems. Manufacturers are exploring opportunities to develop novel ion exchange resins with improved capacity, selectivity and longevity tailored for the pharmaceutical industry.
Threat of new entrants: The threat of new entrants is moderate due to strict regulations and requirement for substantial investments to build production capacity and distribution network.
Bargaining power of buyers: The bargaining power of buyers is high given the presence of numerous established pharmaceutical water providers and the availability of substitutes.
Bargaining power of suppliers: The bargaining power of suppliers is moderate due to availability of substitute raw materials.
Threat of new substitutes: The threat of substitutes is low as pharmaceutical water has limited substitutes for its applications in manufacturing of drugs.
Competitive rivalry: The competitive rivalry is high among the major players operating in the market.
The Global Pharmaceutical Water Market Size is expected to witness high growth.
Regional analysis: The North American region currently dominates the pharmaceutical water market owing to robust presence of major pharmaceutical companies and stringent norms pertaining to water treatment in pharmaceutical applications. The Asia Pacific region is expected to witness fastest growth over the forecast period led by India, China and other emerging Asian countries.
Key players operating in the pharmaceutical water market are Suez, Veolia Water Technologies, Dégrémont, DOW Water & Process Solutions, Pall Corporation, Hydranautics, Danaher Corporation, Avantor Performance Materials, Endress+Hauser, Finch Holdings, and General Electric.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it